Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,197 evidence items · page 28 / 48

50 %Moins de la moitié des femmes avaient réalisé leur première consultation prénatale au premier trimestre de la grossesse au Burkina Faso et au Mali.

Burkina Faso · MaligrossesseHAL · Unilimdocument of 302 observations

4,001 casesFrom May 2024 to February 2025, 4,001 uncomplicated malaria cases were confirmed in the Kidal region.

Malipaludismeobserved 2024-2025HAL · Unilimdocument of 80 observations

69.6 %Protective efficacy of artesunate-amodiaquine against malaria infection was 69.6% in school-aged children in Mali.

Malipaludismepublished 2018Parasite epidemiology and controleurope_pmcdocument of 6 observations

247,000,000 casEn 2021, le nombre de cas de paludisme dans le monde était estimé à 247 millions par l'Organisation mondiale de la Santé.

Malipaludismeobserved 2021HAL · Unilimdocument of 214 observations

The prevalence of severe stunting was higher in the combined group compared to RTS,S/AS01 E alone in 2017.

Burkina Faso · Malipaludismeobserved 2017published 2022Malaria journaleurope_pmcdocument of 7 observationsDOI 10.1186/s12936-022-04077-x

14 health_districts14 health districts were qualified for five rounds of Malaria Seasonal Chemoprevention, 33 for four rounds, and 10 for three rounds.

MalipaludismeHAL · Unilimdocument of 95 observations

15 odds_ratioThe odds ratio for interference between heterozygous G6PD (A−) and sickle cell trait in female children was 15 with a 95% confidence interval of 2.07–132.31 and P = 0.003.

MaliG6PD (A−) deficiency · paludisme · trait drépanocytairepublished 2011American Journal of HematologyOpenAlexdocument of 9 observationsDOI 10.1002/ajh.22093

165,000,000 casEn 2021, les cas de paludisme ont augmenté de 165 millions à 168 millions par rapport à 2020.

Malipaludismeobserved 2020 à 2021HAL · Unilimdocument of 214 observations

57.7 %The combination of RTS,S/AS01 E and SMC had a protective efficacy of 57.7% against clinical malaria compared with SMC alone over the 5-year period.

Malipaludismepublished 2024The Lancet. Infectious diseaseseurope_pmcdocument of 12 observationsDOI 10.1016/s1473-3099(23)00368-7

99.64 %The negative predictive value (NPV) of HemotypeSC® for detecting sickle cell disease was 99.64% (95% CI: 99.44–99.83).

MalidrépanocytoseHAL · Unilimdocument of 103 observations

1.34 odds_ratioThe association between the minor allele of the E670G polymorphism and severe malaria had an odds ratio of 1.34.

Malipaludismepublished 2018PloS oneeurope_pmcdocument of 6 observationsDOI 10.1371/journal.pone.0192850

19 health districtsThe vaccination target is children aged 5–36 months in 19 priority health districts.

MalipaludismeHAL · Unilimdocument of 95 observations

743 deathsFrom January 3, 2020, to November 22, 2023, 743 deaths due to COVID-19 have been reported in Mali.

MaliCOVID-19observed January 3, 2020 to November 22, 2023HAL · Unilimdocument of 88 observations

1.91 %La prévalence globale des gamétocytes variait d’un mois à l’autre selon l’année, avec une prévalence moyenne de 1,91 % dans le dépistage actif.

MalipaludismeHAL · Unilimdocument of 214 observations

6.5 %The prevalence rate of Plasmodium malariae was 6.5% in the Dogon population.

Malipaludismepublished 2017PloS oneeurope_pmcdocument of 14 observationsDOI 10.1371/journal.pone.0189724

99.67 %HemotypeSC® had a specificity of 99.67% (95% CI: 99.48–99.85) to detect sickle cell disease.

MalidrépanocytoseHAL · Unilimdocument of 103 observations

3 %Less than 3% of all samples carried mutations in the pfkelch13 gene.

Malipaludismeobserved 2013 to 2014published 2017Infectious diseases of povertyeurope_pmcdocument of 6 observations

57 health districtsThe risk stratification of Mali in 2023 identified 57 health districts eligible for the SMC versus 59 in the first stratification.

Malipaludismeobserved 2023HAL · Unilimdocument of 95 observations

1.64 %Among 3648 newborns diagnosed by HPLC in Mali from April 2021 to August 2021, 1.64% had sickle cell disease.

Malidrépanocytoseobserved April 2021 to August 2021HAL · Unilimdocument of 103 observations

51.32 %Individuals aged 15 years and older accounted for 51.32% of total malaria cases in the Kidal region from week 23 in 2024 (May) to week 5 in 2025 (February).

Malipaludismeobserved 2024-2025HAL · Unilimdocument of 80 observations

0 %The prevalence rate of Plasmodium ovale was 0% in the Fulani population.

Malipaludismepublished 2017PloS oneeurope_pmcdocument of 14 observationsDOI 10.1371/journal.pone.0189724

296 casesFrom June 2009 to May 2010, 296 clinical malaria cases were recorded in Bandiagara, Mali.

Malipaludismeobserved June 2009 to May 2010published 2013Malaria journaleurope_pmcDOI 10.1186/1475-2875-12-82

97 %Dans le bras intervention, 482 des 495 patients fébriles (97 %) ont reçu un test antigénique rapide pour le paludisme, dont 372 étaient positifs (77 %).

Malipaludismeobserved 2022HAL · Unilimdocument of 36 observations

37 %In Mali in 2023, malaria accounted for a morbidity of 37% of cases at the national level.

Malipaludismeobserved 2023HAL · Unilimdocument of 95 observations

251 per_1000_person_yearsDistricts with incidence rates between 251 and 450 cases per 1,000 person-years or Pf/Pv prevalence between 10% and 35% were classified as 'Moderate Transmission Zones'.

Malipaludisme · Pf/PvHAL · Unilimdocument of 95 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.